Preliminary Results of Radiation Therapy for Prostate Cancer in Human Immunodeficiency Virus-Positive Patients

Urology

Volumn 72, Issue 5, 2008, Pages 1135-1138

  Ng, Tracy ^a,b,e   Stein, Nicholas F ^a   Kaminetsky, Jed ^c   Berman, Steven ^d   Marans, Hillel Y ^b,d   McDermott, Bill ^a   Berson, Anthony M ^a,b,e  

^a ST VINCENT S COMPREHENSIVE CANCER CENTER   (United States)

^b ST VINCENT S HOSPITAL   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d BETH ISRAEL MEDICAL CENTER   (United States)

^e NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER PATIENT; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VIRUS LOAD;

AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VIRAL LOAD;

EID: 54449089345     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.01.022     Document Type: Article

References (18)

1. Roach P.J., Fleming C., and Hagen M.D. Prostatic cancer in a patient with asymptomatic HIV infection: are some lives more equal than others?. Med Decis Making 8 (1988) 132-144
2. Gastaut J.L., Cesaro P., Sobel A., et al. Progressive encephalopathy in an 82-year-old patient with HIV positive serology and prostatic cancer. Rev Neurol 147 (1991) 251-257
3. Schwartz J.D., and Prince D. Prostate cancer in HIV infection. AIDS 10 (1996) 797-798
4. Staiman V., and Lowe F.C. Prostatic disease in HIV infected patients. Infect Urol 9 (1996) 42-47
5. Levinson A., Nagler E.A., and Lowe F.C. Approach to management of clinically localized prostate cancer in patients with human immunodeficiency virus. Urology 65 (2004) 91-94
6. O'Connor J.K., Nedzi L.A., and Zakris E.L. Prostate adenocarcinoma and human immunodeficiency virus: report of three cases and review of the literature. Clin Genitourin Cancer 5 (2006) 85-88
7. Crum N.F., Hale B., Utz G., et al. Increased risk of prostate cancer in HIV infection. AIDS 16 (2002) 1703-1704
8. Huang W.C., Kwon E.O., Scardino P.T., et al. Radical prostatectomy in patients infected with human immunodeficiency virus. BJU Int 98 (2006) 303-307
9. Quatan N., Nair S., and Harrowes F. Should HIV patients be considered a high risk group for the development of prostate cancer?. Ann R Coll Surg Engl 87 (2005) 437-438
10. Manfredi R., Fulgaro C., Sabbatani S., et al. Disseminated, lethal prostate cancer during human immunodeficiency virus infection presenting with non-specific features: open questions for urologists, oncologists, and infectious disease specialists. Cancer Detect Prev 30 (2006) 20-23
11. Furco A., Bani-Sadr F., Guymar S., et al. Metastatic cancer of the prostate in a young 40 year-old HIV-infected patient. Presse Med 32 (2003) 930-931
12. Burgi A., Brodine S., Wegner S., et al. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals. Cancer 104 (2005) 1505-1511
13. Biggar R.J., Engels E.A., and Ly S. Survival after cancer diagnosis in persons with AIDS. J Acquir Immune Defic Syndr 39 (2005) 293-299
14. Mocroft A., Brettle R., Kirk O., et al. Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA Study. AIDS 16 (2002) 1663-1671
15. Miller N.L., Bissonette E.A., Bahnson R., et al. Impact of a novel neoadjuvant and adjuvant hormone-deprivation approach on quality of life, voiding function, and sexual function after brachytherapy. Cancer 97 (2002) 1203-1210
16. Krupski T., Petroni G.R., Bissonette E.A., et al. Quality-of-life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancer. Urology 55 (2000) 736-742
17. Bhatnagar V., Stewart S.T., Huynh V., et al. Estimating the risk of long-term erectile, urinary and bowel symptoms resulting from prostate cancer treatment. Prostate Cancer Prostat Dis 9 (2006) 136-146
18. Zelefsky M.J., Fuks Z., Happersett L., et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol 55 (2000) 241-249